Skip to main content
Premium Trial:

Request an Annual Quote

Nitto Denko Acquires Avecia Biotechnology

Premium

Japan's Nitto Denko said this week that it has acquired Massachusetts-based nucleic acid manufacturer Avecia Biotechnology.

Terms of the acquisition were not disclosed.

The deal, Nitto Denko said, represents “a significant commitment … to the nucleic acids drug industry.” The company recently forged a collaboration with Quark Pharmaceuticals to develop siRNA-based drugs for fibrotic diseases (GSN 7/15/2010).

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.